EPSTEIN-BARR VIRUS
Abbott RealTime EBV
For more information, contact Abbott.
For more information, contact Abbott.
| PRODUCT NAME | UNIT SIZE | ORDER NUMBER | GTIN |
|---|
Accurate quantitation of the Epstein-Barr Virus (EBV) is critical to the monitoring of post-transplant lymphoproliferative disease (PTLD) in immunocompromised graft recipients. The Abbott RealTime EBV assay provides precise, reliable viral load results for supporting clinical management decisions.
Abbott RealTime EBV assay has a low limit of quantification (corresponding to high sensitivity), which is helpful in transplant patients.
To learn more about Abbott RealTime EBV please visit: https://www.molecular.abbott/int/en/products/infectious-disease/realtime-ebv
| ABBOTT REALTIME EBV | |
| Instrumentation | Extraction:m200sp Amplification, detection & result interpretation: m2000rt |
| Technology | Quantitative real-time PCR |
| Probe Design | Single-stranded linear probes |
| Target Region | EBV BLLF1 gene |
| Limit of Detection (LoD) | 40 IU/mL (plasma) 150 IU/mL (whole blood) |
| Quantitation Range | From LoD up to 2 x 108 IU/mL |
| Analytical specificity/ Cross reactivity | 100% |
| Precision | SD: < 0.35 log IU/mL |
| Reported Results | IU/mL, log IU/mL |
| Standardization | 1st WHO International Standard for Epstein-Barr Virus for Nucleic Acid Amplification Techniques (NIBSC 09/260) |
| Sample Tyles | Plasma and whole blood |
| Sample Input Volume | 0.5 mL (plasma), 0.3mL (whole blood) |
| Internal Control | Processed with each sample |
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.